ÂÜÀòÂÒÂ×

Jack Carter, PhD, currently serves as Principal Scientist, Biology at Prelude Therapeutics, where responsibilities include leading pre-clinical drug discovery programs and managing a laboratory team. Notable achievements include first author publications, presentations at prominent conferences, and multiple CEO Recognition Awards. Prior experience includes roles as Senior Research Scientist and Research Scientist, focusing on pre-clinical discovery and translational research. Carter's academic foundation includes a PhD in Cell and Molecular Biology and a BS in Biology from the University of the Sciences in Philadelphia, along with postdoctoral research in cancer biology at the Sidney Kimmel Cancer Center.